NMN Conference, May 9-10, 2025 – Vienna, Austria

We would like to inform you that the abstract submission and registration for the NMN 2025 conference, to be held on May 9-10 2025, are open!
„Diagnostic and Therapeutic Innovations in the Era of Precision Medicine – Nuclear Medicine Meets Neuro-Oncology“ 

You can find all information including the full program and the registration page here: https://www.nmn-society.org/.
Abstract submission and registration are possible via these weblinks. 

The NMN symposium aims to provide a highly interactive platform for scientific and educational exchange on the fascinating and clinically highly relevant aspects in research and application of nuclear medicine with a focus on malignancies of the central nervous system (CNS). Primary and secondary CNS tumors represent a particularly challenging and heterogenous disease entity, which is also characterized by a multitude of molecular alterations. Nuclear medicine is of particular relevance and carries an exceptionally high potential for improvements of diagnosis, molecular classification, planning of therapeutic interventions (neurosurgery, radiotherapy, targeted therapy, immunotherapy), assessment of therapy response and drug development (including assessment of blood-brain barrier penetration) in the field of Neuro-Oncology.

Organizers:
Nathalie Albert & Matthias Preusser

Scientific Committee:

Nathalie L. Albert, Munich
Matthias Preusser, Vienna
Martin van den Bent, Rotterdam
Michael Weller, Zurich
Jolanta Kunikowska, Warsaw
Emilie Le Rhun, Zurich
Norbert Galldiks, Cologne
Marcus Hacker, Vienna
Giuseppe Minniti, Rome
Roberta Rudà, Turin
Karl Rössler, Vienna

Patrick Wen, Boston
Eng-Siew Koh, Sydney
Erik Sulman, New York
Jörg-Christian Tonn, Munich
Wim Oyen, Milan/Arnhem
Andrew Scott, Melbourne
Anna Berghoff, Vienna
Nelleke Tolboom, Utrecht
Francesco Cicone, Catanzaro
Evanthia Galanis, Rochester